🇺🇸 FDA
Pipeline program

Avamys aqueous nasal spray 110mcg

112185

Approved small_molecule completed

Quick answer

Avamys aqueous nasal spray 110mcg for Rhinitis, Allergic, Perennial is a Approved program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Rhinitis, Allergic, Perennial
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials